Circular RNAs: biology and clinical significance of breast cancer

References

• Heer E, Harper A, Escandor N, et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8(8):e1027–e1037. doi: 10.1016/s2214-109x(20)30215-1
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Holm J, Eriksson L, Ploner A, et al. Assessment of breast cancer risk factors reveals subtype heterogeneity. Cancer Res. 2017;77(13):3708–3717. doi: 10.1158/0008-5472.Can-16-2574
   PubMed Web of Science ®Google Scholar
• Gong Y, Ji P, Yang Y-S, et al. Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets. Cell Metab. 2021;33(1):51–64 e59. doi: 10.1016/j.cmet.2020.10.012
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Connolly JL, Edge SB, et al. Breast cancer—major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(4):290–303. doi: 10.3322/caac.21393
   PubMed Web of Science ®Google Scholar
• Jin X, Demere Z, Nair K, et al. A metastasis map of human cancer cell lines. Nature. 2020;588(7837):331–336. doi: 10.1038/s41586-020-2969-2
   PubMed Web of Science ®Google Scholar
• Burgess DJ. Epigenetics: therapy-induced transcription is cryptically widespread. Nat Rev Cancer. 2017;17(8):456. doi: 10.1038/nrc.2017.57
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao K, Xu X, et al. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. Nat Commun. 2018;9(1):4475. doi: 10.1038/s41467-018-06862-2
   PubMed Web of Science ®Google Scholar
• Jiang T, Xia Y, Lv J, et al. A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling. Mol Cancer. 2021;20(1):66. doi: 10.1186/s12943-021-01358-y
   PubMed Web of Science ®Google Scholar
• Grosselin K, Durand A, Marsolier J, et al. High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer. Nature Genet. 2019;51(6):1060–1066. doi: 10.1038/s41588-019-0424-9
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi: 10.1038/nature11928
   PubMed Web of Science ®Google Scholar
• Dong R, Ma XK, Li GW, et al. Circpedia v2: an updated database for comprehensive circular RNA annotation and expression comparison. Int J Genomics Proteomics. 2018;16(4):226–233. doi: 10.1016/j.gpb.2018.08.001
   Google Scholar
• Conn SJ, Pillman K, Toubia J, et al. The RNA binding protein quaking regulates formation of circRnas. Cell. 2015;160(6):1125–1134. doi: 10.1016/j.cell.2015.02.014
   PubMed Web of Science ®Google Scholar
• Chen T, Wang X, Li C, et al. CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation. Oncogene. 2021;40(15):2756–2771. doi: 10.1038/s41388-021-01739-z
   PubMed Web of Science ®Google Scholar
• Du WW, Li X, Ma J, et al. Promotion of tumor progression by exosome transmission of circular RNA circSKA3. Mol Ther Nucleic Acids. 2022;27:276–292. doi: 10.1016/j.omtn.2021.11.027
   PubMedGoogle Scholar
• Sang Y, Chen B, Song X, et al. circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther. 2019;27(9):1638–1652. doi: 10.1016/j.ymthe.2019.05.011
   PubMed Web of Science ®Google Scholar
• Wang L, Yi J, Lu L-Y, et al. Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes. Theranostics. 2021;11(4):1732–1752. doi: 10.7150/thno.45302
   PubMed Web of Science ®Google Scholar
• Yuan C, Zhou L, Zhang L, et al. Identification and integrated analysis of key differentially expressed circular RNAs in ER-positive subtype breast cancer. Epigenomics. 2019;11(3):297–321. doi: 10.2217/epi-2018-0147
   PubMed Web of Science ®Google Scholar
• Wu X, Ren Y, Yao R, et al. Circular RNA circ-MMP11 contributes to lapatinib resistance of breast cancer cells by regulating the miR-153-3p/ANLN axis. Front Oncol. 2021;11:639961. doi: 10.3389/fonc.2021.639961
   PubMed Web of Science ®Google Scholar
• Liang G, Ling Y, Lin Q, et al. MiR-92b-3p inhibits proliferation of HER2-positive breast cancer cell by targeting circCDYL. Front Cell Dev Biol. 2021;9:707049. doi: 10.3389/fcell.2021.707049
   PubMed Web of Science ®Google Scholar
• Li J, Ma M, Yang X, et al. Circular HER2 RNA positive triple negative breast cancer is sensitive to pertuzumab. Mol Cancer. 2020;19(1):142. doi: 10.1186/s12943-020-01259-6
   PubMed Web of Science ®Google Scholar
• Zheng X, Huang M, Xing L, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19(1):73. doi: 10.1186/s12943-020-01183-9
   PubMed Web of Science ®Google Scholar
• Chen B, Wei W, Huang X, et al. circEPSTI1 as a prognostic Marker and Mediator of triple-negative breast cancer progression. Theranostics. 2018;8(14):4003–4015. doi: 10.7150/thno.24106
   PubMed Web of Science ®Google Scholar
• He R, Liu P, Xie X, et al. circGFRA1 and GFRA1 act as ceRnas in triple negative breast cancer by regulating miR-34a. J exper cli can res : CR. 2017;36(1):145. doi: 10.1186/s13046-017-0614-1
   PubMed Web of Science ®Google Scholar
• Tang H, Huang X, Wang J, et al. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer. Mol Cancer. 2019;18(1):23. doi: 10.1186/s12943-019-0946-x
   PubMed Web of Science ®Google Scholar
• Dou D, Ren X, Han M, et al. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell Int. 2020;20(1):454. doi: 10.1186/s12935-020-01547-7
   PubMed Web of Science ®Google Scholar
• Ye F, Gao G, Zou Y, et al. circFBXW7 inhibits malignant progression by sponging miR-197-3p and encoding a 185-aa protein in triple-negative breast cancer. Mol Ther Nucl Acids. 2019;18:88–98. doi: 10.1016/j.omtn.2019.07.023
   Google Scholar
• Darbeheshti F, Zokaei E, Mansoori Y, et al. Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3. Cancer Cell Int. 2021;21(1):312. doi: 10.1186/s12935-021-02015-6
   PubMed Web of Science ®Google Scholar
• Fan Y, Wang J, Jin W, et al. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer. Mol Cancer. 2021;20(1):25. doi: 10.1186/s12943-021-01321-x
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou Y, Jiang L, et al. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway. Mol Cancer. 2021;20(1):43. doi: 10.1186/s12943-021-01332-8
   PubMed Web of Science ®Google Scholar
• Li H, Xu W, Xia Z, et al. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling. Aging. 2021;13(3):4522–4551. doi: 10.18632/aging.202415
   PubMedGoogle Scholar
• Zeng K, He B, Yang BB, et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer. 2018;17(1):160. doi: 10.1186/s12943-018-0914-x
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–97. doi: 10.1093/nar/gkt1248
   PubMed Web of Science ®Google Scholar
• Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881.e813. doi: 10.1016/j.cell.2018.12.021
   PubMed Web of Science ®Google Scholar
• Li S, Li Y, Chen B, et al. exoRbase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Res. 2018;46(D1):D106–d112. doi: 10.1093/nar/gkx891
   PubMed Web of Science ®Google Scholar
• Ruan H, Xiang Y, Ko J, et al. Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines. Genome Med. 2019;11(1):55. doi: 10.1186/s13073-019-0663-5
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Jakobsen T, Hager H, et al. The emerging roles of circRnas in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188–206. doi: 10.1038/s41571-021-00585-y
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhou Y, Liang G, et al. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019;10(2):55. doi: 10.1038/s41419-018-1287-1
   PubMed Web of Science ®Google Scholar
• Li J, Gao X, Zhang Z, et al. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502–5p/KRAS and IGF2BP2/Myc axes. Mol Cancer. 2021;20(1):138. doi: 10.1186/s12943-021-01444-1
   PubMed Web of Science ®Google Scholar
• Ling Y, Liang G, Lin Q, et al. circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer. Mol Cancer. 2022;21(1):8. doi: 10.1186/s12943-021-01476-7
   PubMed Web of Science ®Google Scholar
• Yu Y, Zheng W, Ji C, et al. Tumor-derived circRnas as circulating biomarkers for breast cancer. Front Pharmacol. 2022;13:811856. doi: 10.3389/fphar.2022.811856
   PubMed Web of Science ®Google Scholar
• Lin L, Cai G-X, Zhai X-M, et al. Plasma-derived extracellular vesicles circular RNAs serve as biomarkers for breast cancer diagnosis. Front Oncol. 2021;11:752651. doi: 10.3389/fonc.2021.752651
   PubMed Web of Science ®Google Scholar
• Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852–3856. doi: 10.1073/pnas.73.11.3852
   PubMed Web of Science ®Google Scholar
• Capel B, Swain A, Nicolis S, et al. Circular transcripts of the testis-determining gene sry in adult mouse testis. Cell. 1993;73(5):1019–1030. doi: 10.1016/0092-8674(93)90279-y
   PubMed Web of Science ®Google Scholar
• Zheng Q, Bao C, Guo W, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRnas. Nat Commun. 2016;7(1):11215. doi: 10.1038/ncomms11215
   PubMed Web of Science ®Google Scholar
• Chen L, Wang C, Sun H, et al. The bioinformatics toolbox for circRNA discovery and analysis. Brief Bioinform. 2021;22(2):1706–1728. doi: 10.1093/bib/bbaa001
   PubMed Web of Science ®Google Scholar
• Panda AC, De S, Grammatikakis I, et al. High-purity circular RNA isolation method (RPAD) reveals vast collection of intronic circRnas. Nucleic Acids Res. 2017;45(12):e116. doi: 10.1093/nar/gkx297
   PubMed Web of Science ®Google Scholar
• Venø MT, Hansen TB, Venø ST, et al. Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development. Genome Biol. 2015;16(1):245. doi: 10.1186/s13059-015-0801-3
   PubMedGoogle Scholar
• Guo JU, Agarwal V, Guo H, et al. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 2014;15(7):409. doi: 10.1186/s13059-014-0409-z
   PubMed Web of Science ®Google Scholar
• Zhang XO, Dong R, Zhang Y, et al. Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. Genome Res. 2016;26(9):1277–1287. doi: 10.1101/gr.202895.115
   PubMed Web of Science ®Google Scholar
• Feng J, Chen K, Dong X, et al. Genome-wide identification of cancer-specific alternative splicing in circRNA. Mol Cancer. 2019;18(1):35. doi: 10.1186/s12943-019-0996-0
   PubMedGoogle Scholar
• Errichelli L, Dini Modigliani S, Laneve P, et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun. 2017;8(1):14741. doi: 10.1038/ncomms14741
   PubMed Web of Science ®Google Scholar
• Li X, Liu C-X, Xue W, et al. Coordinated circRNA biogenesis and function with NF90/NF110 in viral infection. Mol Cell. 2017;67(2):214–227.e217. doi: 10.1016/j.molcel.2017.05.023
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi: 10.1038/s41576-019-0158-7
   PubMed Web of Science ®Google Scholar
• Wu G, Zhou W, Pan X, et al. RETRACTED: circular RNA profiling reveals exosomal circ_0006156 as a novel biomarker in papillary thyroid cancer. Mol Ther Nucleic Acids. 2020;19:1134–1144. doi: 10.1016/j.omtn.2019.12.025
   PubMedGoogle Scholar
• Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–461. doi: 10.1038/nbt.2890
   PubMed Web of Science ®Google Scholar
• Starke S, Jost I, Rossbach O, et al. Exon circularization requires canonical splice signals. Cell Rep. 2015;10(1):103–111. doi: 10.1016/j.celrep.2014.12.002
   PubMed Web of Science ®Google Scholar
• Wang PL, Bao Y, Yee M-C, et al. Circular RNA is expressed across the eukaryotic tree of life. PLoS One. 2014;9(3):e90859. doi: 10.1371/journal.pone.0090859
   PubMed Web of Science ®Google Scholar
• Ivanov A, Memczak S, Wyler E, et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015;10(2):170–177. doi: 10.1016/j.celrep.2014.12.019
   PubMed Web of Science ®Google Scholar
• Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256–264. doi: 10.1038/nsmb.2959
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233. doi: 10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Chen J, Wu Y, Luo X, et al. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer. Theranostics. 2021;11(15):7507–7526. doi: 10.7150/thno.59546
   PubMed Web of Science ®Google Scholar
• Okholm TLH, Sathe S, Park SS, et al. Transcriptome-wide profiles of circular RNA and RNA-binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression. Genome Med. 2020;12(1):112. doi: 10.1186/s13073-020-00812-8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X-O, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51(6):792–806. doi: 10.1016/j.molcel.2013.08.017
   PubMed Web of Science ®Google Scholar
• Chen CK, Cheng R, Demeter J, et al. Structured elements drive extensive circular RNA translation. Mol Cell. 2021;81(20):4300–4318.e4313. doi: 10.1016/j.molcel.2021.07.042
   PubMed Web of Science ®Google Scholar
• Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 2017;27(5):626–641. doi: 10.1038/cr.2017.31
   PubMed Web of Science ®Google Scholar
• Cheng Z, Yu C, Cui S, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019;10(1):3200. doi: 10.1038/s41467-019-11162-4
   PubMed Web of Science ®Google Scholar
• Geng Y, Bao Y, Deng L, et al. Circular RNA hsa_circ_0014130 inhibits apoptosis in non–small cell lung cancer by sponging miR-136-5p and upregulating BCL2. Mol Cancer Res. 2020;18(5):748–756. doi: 10.1158/1541-7786.Mcr-19-0998
   PubMed Web of Science ®Google Scholar
• Yu L, Shi J, Cheng S, et al. Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells. Mol Endocrinol. 2012;26(9):1521–1530. doi: 10.1210/me.2012-1006
   PubMedGoogle Scholar
• Shen P, Yang T, Chen Q, et al. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing. Mol Cancer. 2021;20(1):51. doi: 10.1186/s12943-021-01333-7
   PubMed Web of Science ®Google Scholar
• Eystathioy T, Chan EKL, Tenenbaum SA, et al. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRnas within novel cytoplasmic speckles. Mol Biol Cell. 2002;13(4):1338–1351. doi: 10.1091/mbc.01-11-0544
   PubMed Web of Science ®Google Scholar
• Yang Z, Jakymiw A, Wood MR, et al. GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J Cell Sci. 2004;117(23):5567–5578. doi: 10.1242/jcs.01477
   PubMed Web of Science ®Google Scholar
• Zhang L, Ding L, Cheung TH, et al. Systematic identification of C. elegans miRISC proteins, miRnas, and mRNA targets by their interactions with GW182 proteins AIN-1 and AIN-2. Mol Cell. 2007;28(4):598–613. doi: 10.1016/j.molcel.2007.09.014
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi: 10.1038/nrd.2016.246
   PubMed Web of Science ®Google Scholar
• Bonci D, Coppola V, Musumeci M, et al. The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008;14(11):1271–1277. doi: 10.1038/nm.1880
   PubMed Web of Science ®Google Scholar
• Callegari E, Elamin BK, Giannone F, et al. Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology. 2012;56(3):1025–1033. doi: 10.1002/hep.25747
   PubMed Web of Science ®Google Scholar
• Xia S, Feng J, Chen K, et al. CSCD: a database for cancer-specific circular RNAs. Nucleic Acids Res. 2018;46(D1):D925–d929. doi: 10.1093/nar/gkx863
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi: 10.1038/nature11993
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi: 10.1038/nature12986
   PubMed Web of Science ®Google Scholar
• Cui Y, Fan J, Shi W, et al. Circ_0001667 knockdown blocks cancer progression and attenuates adriamycin resistance by depleting NCOA3 via releasing miR-4458 in breast cancer. Drug Dev Res. 2022;83(1):75–87. doi: 10.1002/ddr.21845
   PubMed Web of Science ®Google Scholar
• Akira S, Maeda K. Control of RNA stability in immunity. Annu Rev Immunol. 2021;39(1):481–509. doi: 10.1146/annurev-immunol-101819-075147
   PubMedGoogle Scholar
• Nyati KK, Zaman MM, Sharma P, et al. Arid5a, an RNA-Binding protein in Immune regulation: RNA stability, inflammation, and autoimmunity. Trends Immunol. 2020;41(3):255–268. doi: 10.1016/j.it.2020.01.004
   PubMed Web of Science ®Google Scholar
• Xia Z, Donehower LA, Cooper TA, et al. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types. Nat Commun. 2014;5(1). doi: 10.1038/ncomms6274
   Google Scholar
• Cai Y, Zhao X, Chen D, et al. Circ-NOL10 regulated by MTDH/CASC3 inhibits breast cancer progression and metastasis via multiple miRnas and PDCD4. Mol Ther Nucl Acids. 2021;26:773–786. doi: 10.1016/j.omtn.2021.09.013
   Google Scholar
• Ng WL, Mohd Mohidin TB, Shukla K. Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018;15:995–1005. doi: 10.1080/15476286.2018.1486659
   PubMed Web of Science ®Google Scholar
• Wang X, Chen M, Fang L. hsa_circ_0068631 promotes breast cancer progression through c-myc by binding to EIF4A3. Mol Ther Nucleic Acids. 2021;26:122–134. doi: 10.1016/j.omtn.2021.07.003
   PubMedGoogle Scholar
• Lebedeva S, Jens M, Theil K, et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell. 2011;43(3):340–352. doi: 10.1016/j.molcel.2011.06.008
   PubMed Web of Science ®Google Scholar
• Yi Z, Li Y, Wu Y, et al. Circular RNA 0001073 attenuates malignant biological behaviours in breast cancer cell and is delivered by Nanoparticles to inhibit mice tumour growth. Onco Targets Ther. 2020;13:6157–6169. doi: 10.2147/ott.S248822
   PubMed Web of Science ®Google Scholar
• Ashwal-Fluss R, Meyer M, Pamudurti N, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. doi: 10.1016/j.molcel.2014.08.019
   PubMed Web of Science ®Google Scholar
• Modahl LE, Macnaughton TB, Zhu N, et al. RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol. 2000;20(16):6030–6039. doi: 10.1128/mcb.20.16.6030-6039.2000
   PubMed Web of Science ®Google Scholar
• Ma J, Du WW, Zeng K, et al. An antisense circular RNA circSCRIB enhances cancer progression by suppressing parental gene splicing and translation. Mol Ther. 2021;29(9):2754–2768. doi: 10.1016/j.ymthe.2021.08.002
   PubMed Web of Science ®Google Scholar
• Wang X, Xing L, Yang R, et al. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC. Mol Cancer. 2021;20(1):91. doi: 10.1186/s12943-021-01383-x
   PubMed Web of Science ®Google Scholar
• Meyer KD, Patil D, Zhou J, et al. 5′ UTR m6A promotes cap-independent translation. Cell. 2015;163(4):999–1010. doi: 10.1016/j.cell.2015.10.012
   PubMed Web of Science ®Google Scholar
• Wagner S, Herrmannová A, Hronová V, et al. Selective translation complex profiling reveals staged initiation and co-translational assembly of initiation factor complexes. Mol Cell. 2020;79(4):546–560.e547. doi: 10.1016/j.molcel.2020.06.004
   PubMed Web of Science ®Google Scholar
• Yan X, Hoek TA, Vale RD, et al. Dynamics of translation of single mRNA molecules in vivo. Cell. 2016;165(4):976–989. doi: 10.1016/j.cell.2016.04.034
   PubMed Web of Science ®Google Scholar
• Gozmanova M, Denti MA, Minkov IN, et al. Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1. Nucleic Acids Res. 2003;31(19):5534–5543. doi: 10.1093/nar/gkg777
   PubMed Web of Science ®Google Scholar
• Pamudurti NR, Bartok O, Jens M, et al. Translation of CircRNAs. Molecular Cell. 2017;66(1):9–21 e27. doi: 10.1016/j.molcel.2017.02.021
   PubMed Web of Science ®Google Scholar
• Bazzini AA, Johnstone TG, Christiano R, et al. Identification of small ORFs in vertebrates using ribosome footprinting and evolutionary conservation. EMBO J. 2014;33(9):981–993. doi: 10.1002/embj.201488411
   PubMed Web of Science ®Google Scholar
• Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer. J Clin Oncol. 2006;24(23):3726–3734. doi: 10.1200/jco.2005.04.7985
   PubMed Web of Science ®Google Scholar
• Niemeier LA, Dabbs DJ, Beriwal S, et al. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol. 2010;23(2):205–212. doi: 10.1038/modpathol.2009.159
   PubMed Web of Science ®Google Scholar
• Osborne CK, Wood AJJ. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339(22):1609–1618. doi: 10.1056/NEJM199811263392207
   PubMed Web of Science ®Google Scholar
• Powles TJ, Ashley S, Tidy A, et al. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst. 2007;99(4):283–290. doi: 10.1093/jnci/djk050
   PubMedGoogle Scholar
• Liu B, Wang T, Wang H, et al. Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer. J Hematol Oncol. 2018;11(1):26. doi: 10.1186/s13045-018-0577-5
   PubMedGoogle Scholar
• Shi Q, Li Y, Li S, et al. LncRNA DILA1 inhibits cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nat Commun. 2020;11(1):5513. doi: 10.1038/s41467-020-19349-w
   PubMed Web of Science ®Google Scholar
• Wang J, Xie S, Yang J, et al. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy. J Hematol Oncol. 2019;12(1):81. doi: 10.1186/s13045-019-0747-0
   PubMedGoogle Scholar
• Liu H, Song Y, Qiu H, et al. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. Cell Death Differ. 2020;27(3):966–983. doi: 10.1038/s41418-019-0389-3
   PubMed Web of Science ®Google Scholar
• Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93–115. doi: 10.1038/nrc.2016.138
   PubMed Web of Science ®Google Scholar
• Burstein HJ. The distinctive nature of HER2-positive breast cancers. N Engl J Med. 2005;353(16):1652–1654. doi: 10.1056/NEJMp058197
   PubMed Web of Science ®Google Scholar
• Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353(16):1659–1672. doi: 10.1056/NEJMoa052306
   PubMed Web of Science ®Google Scholar
• von Minckwitz G, Procter M, de Azambuja E, et al. Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer. N Engl J Med. 2017;377(2):122–131. doi: 10.1056/NEJMoa1703643
   PubMed Web of Science ®Google Scholar
• Swain SM, Baselga J, Kim S-B, et al. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med. 2015;372(8):724–734. doi: 10.1056/NEJMoa1413513
   PubMed Web of Science ®Google Scholar
• Luo L, Zhang Z, Qiu N, et al. Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer. Nat Commun. 2021;12(1):2699. doi: 10.1038/s41467-021-23052-9
   PubMed Web of Science ®Google Scholar
• Zheng G, Guo Z, Li W, et al. Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab. Signal Transduct Target Ther. 2021;6(1):236. doi: 10.1038/s41392-021-00629-w
   PubMed Web of Science ®Google Scholar
• Deblois G, Smith HW, Tam IS, et al. ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer. Nat Commun. 2016;7(1):12156. doi: 10.1038/ncomms12156
   PubMedGoogle Scholar
• Zhou W, Wang Z, Shen N, et al. Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer. Mol Cell Biochem. 2015;398(1–2):11–19. doi: 10.1007/s11010-014-2200-6
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938–1948. doi: 10.1056/NEJMra1001389
   PubMed Web of Science ®Google Scholar
• Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15):4429–4434. doi: 10.1158/1078-0432.CCR-06-3045
   PubMed Web of Science ®Google Scholar
• Asad S, Barcenas CH, Bleicher RJ, et al. Sociodemographic factors associated with rapid relapse in triple-negative breast cancer: a multi-institution study. J Natl Compr Canc Netw. 2021;19(7):797–804. doi: 10.6004/jnccn.2020.7659
   PubMed Web of Science ®Google Scholar
• Wang X, Wang S-S, Huang H, et al. Effect of capecitabine maintenance therapy using lower dosage and higher frequency vs observation on disease-free survival among patients with early-stage triple-negative breast cancer who had received standard treatment: the SYSUCC-001 randomized clinical trial. JAMA. 2021;325(1):50–58. doi: 10.1001/jama.2020.23370
   PubMed Web of Science ®Google Scholar
• Poggio F, Bruzzone M, Ceppi M, et al. Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol. 2018;29(7):1497–1508. doi: 10.1093/annonc/mdy127
   PubMed Web of Science ®Google Scholar
• Yu KD, Ye F-G, He M, et al. Effect of adjuvant paclitaxel and carboplatin on survival in women with triple-negative breast cancer: a phase 3 randomized clinical trial. JAMA Oncol. 2020;6(9):1390–1396. doi: 10.1001/jamaoncol.2020.2965
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Z, Su P, et al. Circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway. Mol Ther. 2022;30(1):415–430. doi: 10.1016/j.ymthe.2021.08.026
   PubMed Web of Science ®Google Scholar
• Khaled WT, Choon Lee S, Stingl J, et al. BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells. Nat Commun. 2015;6(1):5987. doi: 10.1038/ncomms6987
   PubMedGoogle Scholar
• Cao Q, Song Z, Ruan H, et al. Targeting the KIF4A/AR axis to reverse endocrine therapy resistance in castration-resistant prostate cancer. Clin Cancer Res. 2020;26(6):1516–1528. doi: 10.1158/1078-0432.Ccr-19-0396
   PubMed Web of Science ®Google Scholar
• Hu G, Yan Z, Zhang C, et al. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression. J Exp Clin Cancer Res. 2019;38(1):188. doi: 10.1186/s13046-019-1202-3
   PubMed Web of Science ®Google Scholar
• Huang SC, Wei P-C, Hwang‐Verslues WW, et al. TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB. EMBO Mol Med. 2017;9(12):1660–1680. doi: 10.15252/emmm.201606914
   PubMed Web of Science ®Google Scholar
• Liu Q, Hodge J, Wang J, et al. Emodin reduces breast cancer lung metastasis by suppressing macrophage-induced breast cancer cell epithelial-mesenchymal transition and cancer stem cell formation. Theranostics. 2020;10(18):8365–8381. doi: 10.7150/thno.45395
   PubMed Web of Science ®Google Scholar
• Xu YM, Wang H-J, Chen F, et al. HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation. Oncotarget. 2015;6(40):42854–42867. doi: 10.18632/oncotarget.5733
   PubMedGoogle Scholar
• Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490: 61–70. 7418. doi: 10.1038/nature11412
   PubMed Web of Science ®Google Scholar
• Bai F, Zhang L-H, Liu X, et al. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer. Theranostics. 2021;11(17):8218–8233. doi: 10.7150/thno.59280
   PubMed Web of Science ®Google Scholar
• Xu JZ, Shao C-C, Wang X-J, et al. circTada2as suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis. 2019;10(3):175. doi: 10.1038/s41419-019-1382-y
   PubMed Web of Science ®Google Scholar
• Kim C, Gao R, Sei E, et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell. 2018;173(4):879–893 e813. doi: 10.1016/j.cell.2018.03.041
   PubMed Web of Science ®Google Scholar
• Liu Y, Cheng G, Huang Z, et al. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma. Cell Death Dis. 2020;11(7):515. doi: 10.1038/s41419-020-2713-8
   PubMed Web of Science ®Google Scholar
• Kishikawa T, Higuchi H, Wang L, et al. WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer models. J Clin Invest. 2021;131(24). doi: 10.1172/jci140436
   PubMed Web of Science ®Google Scholar
• Lee YR, Yehia L, Kishikawa T, et al. WWP1 gain-of-function inactivation of PTEN in cancer predisposition. N Engl J Med. 2020;382(22):2103–2116. doi: 10.1056/NEJMoa1914919
   PubMed Web of Science ®Google Scholar
• Yin WB, Yan M-G, Fang X, et al. Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection. Clin Chim Acta. 2018;487:363–368. doi: 10.1016/j.cca.2017.10.011
   PubMed Web of Science ®Google Scholar
• Hu Y, Song Q, Zhao J, et al. Identification of plasma hsa_circ_0008673 expression as a potential biomarker and tumor regulator of breast cancer. J Clin Lab Anal. 2020;34(9):e23393. doi: 10.1002/jcla.23393
   PubMed Web of Science ®Google Scholar
• Li X, Ma F, Wu L, et al. Identification of Hsa_circ_0104824 as a potential biomarkers for breast cancer. Technol Cancer Res Treat. 2020;19:1533033820960745. doi: 10.1177/1533033820960745
   Web of Science ®Google Scholar
• Liu J, Peng X, Liu Y, et al. The diagnostic value of Serum exosomal Has_circ_0000615 for breast cancer patients. Int J Gen Med. 2021;14:4545–4554. doi: 10.2147/ijgm.S319801
   PubMed Web of Science ®Google Scholar
• Wang YW, Xu Y, Wang Y-Y, et al. Elevated circRnas circ_0000745, circ_0001531 and circ_0001640 in human whole blood: potential novel diagnostic biomarkers for breast cancer. Exp Mol Pathol. 2021;121:104661. doi: 10.1016/j.yexmp.2021.104661
   PubMed Web of Science ®Google Scholar
• Ameli-Mojarad M, Ameli-Mojarad M, Nourbakhsh M, et al. Circular RNA hsa_circ_0005046 and hsa_circ_0001791 May become diagnostic biomarkers for breast cancer early detection. J Oncol. 2021;2021:2303946. doi: 10.1155/2021/2303946
   PubMed Web of Science ®Google Scholar
• Li Y, Li H. Circular RNA VRK1 correlates with favourable prognosis, inhibits cell proliferation but promotes apoptosis in breast cancer. J Clin Lab Analysis. 2020;34(1):e22980. doi: 10.1002/jcla.22980
   PubMed Web of Science ®Google Scholar
• Liu C, Chen M, Shi Y. Downregulation of hsa_circ_0006220 and its correlation with clinicopathological factors in human breast cancer. Gland Surg. 2021;10(2):816–825. doi: 10.21037/gs-21-42
   PubMed Web of Science ®Google Scholar
• Liu C, Han T, Shi Y. The decreased expression of hsa_circ_0043278 and its relationship with clinicopathological features of breast cancer. Gland Surg. 2020;9(6):2044–2053. doi: 10.21037/gs-20-825
   PubMed Web of Science ®Google Scholar
• Lü LS, Sun J, Shi P, et al. Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer. Oncotarget. 2017;8(27):44096–44107. doi: 10.18632/oncotarget.17307
   PubMedGoogle Scholar
• Lü L, Sun J, Shi P, et al. Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer. Oncotarget. 2017;8(27):44096–44107. doi: 10.18632/oncotarget.17307
   PubMedGoogle Scholar
• cancer.org|1.800.227.2345
   Google Scholar
• Wang S, Xue X, Wang R, et al. CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p. Cancer Manage Res. 2018;10:3881–3890. doi: 10.2147/cmar.S174778
   PubMed Web of Science ®Google Scholar
• Xu JH, Wang Y, Xu D. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer. Cancer Biomark. 2019;25(2):193–201. doi: 10.3233/cbm-182293
   PubMed Web of Science ®Google Scholar
• Zou Y, Zheng S, Xiao W, et al. circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression. Carcinogenesis. 2019;40:1469–1479. doi: 10.1093/carcin/bgz071
   PubMed Web of Science ®Google Scholar
• Zhang X, Su X, Guo Z, et al. Circular RNA La-related RNA-binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancer. J Clin Lab Analysis. 2020;34(7):e23272. doi: 10.1002/jcla.23272
   PubMed Web of Science ®Google Scholar
• Cai F, Fu W, Tang L, et al. Hsa_circ_0000515 is a novel circular RNA implicated in the development of breast cancer through its regulation of the microRNA-296-5p/CXCL10 axis. FEBS J. 2021;288(3):861–883. doi: 10.1111/febs.15373
   PubMed Web of Science ®Google Scholar
• Zhou B, Mo Z, Lai G, et al. Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-?B-IL-6 axis of tumor-associated macrophages. J Exp Clin Cancer Res. 2023;42(1):48. doi: 10.1186/s13046-023-02620-5
   PubMed Web of Science ®Google Scholar
• Rivera E, Gomez H. Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res. 2010;12(S2):S2. doi: 10.1186/bcr2573
   PubMedGoogle Scholar
• Liu G, Zhang Z, Song Q, et al. Circ_0006528 contributes to paclitaxel resistance of breast cancer cells by regulating miR-1299/CDK8 axis. Onco Targets Ther. 2020;13:9497–9511. doi: 10.2147/ott.S252886
   PubMed Web of Science ®Google Scholar
• Yang W, Gong P, Yang Y, et al. Circ-ABCB10 contributes to paclitaxel resistance in breast cancer through let-7a-5p/DUSP7 axis. Cancer Manage Res. 2020;12:2327–2337. doi:10.2147/cmar.S238513
   PubMed Web of Science ®Google Scholar
• Zang H, Li Y, Zhang X, et al. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Thoracic Cancer. 2020;11(7):1891–1903. doi: 10.1111/1759-7714.13475
   PubMed Web of Science ®Google Scholar
• Hao J, Du X, Lv F, et al. Knockdown of circ_0006528 suppresses cell proliferation, migration, invasion, and Adriamycin chemoresistance via regulating the miR-1236-3p/CHD4 axis in breast cancer. J Surg Res. 2021;260:104–115. doi: 10.1016/j.jss.2020.10.031
   PubMed Web of Science ®Google Scholar
• Huang L, Ma J, Cui M. Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells. Immunol Res. 2021;69(6):558–567. doi: 10.1007/s12026-021-09237-w
   PubMed Web of Science ®Google Scholar
• Wang S, Wang Y, Li Q, et al. A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis. Environ Toxicol. 2022;37(7):1597–1607. doi: 10.1002/tox.23509
   PubMed Web of Science ®Google Scholar
• Vernieri C, Milano M, Brambilla M, et al. Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives. Crit Rev Oncol Hematol. 2019;139:53–66. doi: 10.1016/j.critrevonc.2019.05.001
   PubMed Web of Science ®Google Scholar
• Zhang H, Yan C, Wang Y. Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer. J Drug Target. 2021;29(9):1004–1015. doi: 10.1080/1061186x.2021.1906882
   PubMed Web of Science ®Google Scholar
• Li S, Teng S, Xu J, et al. Microarray is an efficient tool for circRNA profiling. Brief Bioinform. 2019;20(4):1420–1433. doi: 10.1093/bib/bby006
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu Y, Min Z, et al. circMine: a comprehensive database to integrate, analyze and visualize human disease–related circRNA transcriptome. Nucleic Acids Res. 2022;50(D1):D83–d92. doi: 10.1093/nar/gkab809
   PubMed Web of Science ®Google Scholar
• Hussen BM, Mohamadtahr S, Abdullah SR, et al. Exosomal circular RNAs: New player in breast cancer progression and therapeutic targets. Front Genet. 2023;14:1126944. doi: 10.3389/fgene.2023.1126944
   PubMed Web of Science ®Google Scholar